Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Corporate & Fiscal
Pharmaceutical Events & Conferences
Terms & Conditions
What does the future hold for cell-based assays in pharma? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions.
Our study analyses products and services for cell-based testing. It covers activities of product developers and pre-clinical contract research organisations.
You discover sales predictions to 2022 at world market, main submarket and national levels. Find potential revenues for products and services.
Also, you receive discussions of many companies in the cell assay industry, seeing their activities and outlooks.
Companies featured include the following:
• BD Biosciences
• Life Technologies
• Beckman Coulter
• GE Healthcare
• Thermo Fisher Scientific
• Charles River Laboratories
• MD Biosciences.
Looking ahead to 2022, many commercial opportunities exist for cell-based testing. Our report gives you business research and analysis there.
Where are cellular assays heading? Greater need for cellular information earlier in pre-clinical product development stimulates demand for the tests. Our report shows you how their use is increasing in drug discovery and development.
Which developmental processes will benefit most from cell assays? This decade, drug screening and toxicity testing will be important applications for cell-based products and services, our analysis shows.
At present, half of all assays used in pharmaceutical development are cell-based. Miniaturisation and automation are important. We find wide scope for developing the systems and applications from 2012 to 2022, seeing many opportunities.
What are the limitations of cell-based assays? For their potential to be achieved, challenges must be tackled. Systems such as 3D assays will allow for more-accurate simulation of in vivo conditions in cell cultures. Our report explains.
Visiongain's study provides data, analysis and opinion aiming to benefit your research, calculations and presentations. You find answers now in our work.
Revenue forecasts, market shares, developmental trends and discussions
In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (SWOT and STEP) and discussion of technologies, existing and in development. You receive 74 tables and charts and two research interviews.
Advantages of Cell-Based Assays: World Market Prospects 2012-2022 for your work
In particular, this study gives you the following knowledge:
• Find potential revenues to 2022 for the world market and submarkets
• See market forecasting to 2022 for US, Japan, EU5, China and India
• Assess leading companies, discovering activities and outlooks
• Review technological developments, assessing trends and prospects
• Investigate competition and opportunities influencing revenues
• Find out what will stimulate and restrain the industry and market
• Analyse pharma R&D spending by stage and find an overall forecast to 2022
• View opinions from our survey, receiving detailed interviews.
There, you find a distinctive mix of quantitative and qualitative analyses with independent predictions. Without our report, you could miss out on information that your competitors are using.
We analyse developments and prospects in cellular testing, helping you to stay ahead.
AB SCIEX (a subsidiary of Danaher)
Accuri Cytometers (now part of BD)
Agilent Automation Solutions
Apredica (now part of Cyprotex)
ATCC (formerly the American Type Culture Collection) [US]
Aurigene Discovery Technologies (a subsidiary of Dr Reddy's Laboratories)
BD Biosciences (a division of Becton, Dickinson & Co - BD)
Beckman Coulter (now part of Danaher)
Becton, Dickinson & Co.
Caliper Discovery Alliances and Services (CDAS, a subsidiary of Caliper Life Sciences)
Caliper Life Sciences (now part of PerkinElmer)
Cellomics (now part of Thermo Fisher Scientific)
Cellular Dynamics International
Charles River Laboratories
Corning Life Sciences
Dr. Reddy's Laboratories
European Collection of Cell Culture (ECACC)
European Commission (EC)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Evotec Technologies (a subsidiary of PerkinElmer)
GE Healthcare (a division of General Electric)
Genentech (part of Roche)
General Electric (GE)
Harvard NeuroDiscovery Center
Jubilant Biosys (a subsidiary of Jubilant Life Sciences)
Jubilant Life Sciences
Leica Microsystems (a subsidiary of Danaher)
Marin Biologic Laboratories
MDS Analytical Technologies (now part of Danaher)
Ministry of Education, Culture, Sports, Science and Technology [Japan]
Molecular Devices (a subsidiary of Danaher)
MRC (Medical Research Council) Technology
NovaScreen Biosciences (part of Caliper Life Sciences)
Pharmaceutical Research and Manufacturers of America (PhRMA)
Proteome Sciences R&D
Q3DM (part of Beckman Coulter)
Radiometer (a subsidiary of Danaher)
Roche Applied Science (a division of Roche)
Sentigen Holding (part of Life Technologies)
Stem Cell Innovations
Thermo Fisher Scientific
Tumour Biology Center Freiburg
University of Kyoto
University of Michigan
University of Tübingen
World Trade Organization (WTO)
Xenogen Biosciences (formerly part of Caliper Life Sciences, acquired by Taconic in 2009)